2m 2m 2m 2m 2m 2m 2m
Cytokinetics (CYTK)
NASDAQ
$75.59-$1.25 (-1.63%)
Price as of Aug 21, 2026 7:30 PM EDT- $10.7BMarket Cap
- 100.42%1-Year Change
- BiotechnologyIndustry
Cytokinetics (CYTK)
$75.59-$1.25 (-1.63%)
CYTK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $76.84 | ||
Change | -$0.34 (-0.44%) | ||
Open | $77.30 | ||
High | $77.70 | ||
Low | $76.65 | ||
Previous Close | $77.18 | ||
Volume | 1,521,261 | ||
30-Day Average Volume | 1,884,691 | ||
1-Week Change | 3.66% | ||
1-Month Change | -5.26% | ||
1-Year Change | 100.42% | ||
3-Year Change | 133.27% | ||
5-Year Change | 151.44% | ||
Fundamentals | |||
Shares Outstanding | 139.0M | ||
Total Assets | $1.9B | ||
Market Cap | $10.7B | ||
Enterprise Value | $10.7B | ||
Period: QTR TTM FY | |||
Revenue | $25.3M | ||
Net Income | -$198.8M | ||
Free Cash Flow | -$164.2M | ||
EBIT | -$184.1M | ||
EBITDA | -$180.5M | ||
Net Working Capital | $1.0B | ||
EPS | -$1.50 | ||
Enterprise Value/EBITDA | -59 | ||
Enterprise Value/Revenue | 422 | ||
P/B | -62 | ||
P/E | -51 | ||
PEG | -5 | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/25/2013 | ||
Earnings & Revenue